COVID-19 is a novel viral disease, and there is no pre-existing immunity in our community. This project will target this need, through design and synthesis of nanoparticles-based antiviral materials and testing their efficiency on different surfaces. This project will involve the design and synthesis of a range of nanoparticles, their characterisation and immobilisation as well as investigation on their virus-killing properties on different surfaces.

Project members

Dr Nasim Amiralian

Group Leader and Advance Queensland Research Fellow
Amiralian Group

Professor Alan Rowan

AIBN Institute Director
Senior Group Leader
Rowan Group

Dr Jan Lauko

Postdoctoral researcher - Group Operations Manager
Rowan group

Divya Rajah

PhD Student
Rowan Group & Amiralian Group